These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 16816393)

  • 1. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding.
    Cervenka S; Pålhagen SE; Comley RA; Panagiotidis G; Cselényi Z; Matthews JC; Lai RY; Halldin C; Farde L
    Brain; 2006 Aug; 129(Pt 8):2017-28. PubMed ID: 16816393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased striatal dopamine transporter density in moderately severe old restless legs syndrome patients.
    Kim KW; Jhoo JH; Lee SB; Lee SD; Kim TH; Kim SE; Kim YK; Yoon IY
    Eur J Neurol; 2012 Sep; 19(9):1213-8. PubMed ID: 22435397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spinocerebellar ataxia type 1, 2, and 3 and restless legs syndrome: striatal dopamine D2 receptor status investigated by [11C]raclopride positron emission tomography.
    Reimold M; Globas C; Gleichmann M; Schulze M; Gerloff C; Bares R; Machulla HJ; Bürk K
    Mov Disord; 2006 Oct; 21(10):1667-73. PubMed ID: 16941469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
    Turjanski N; Lees AJ; Brooks DJ
    Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans.
    Cervenka S; Varrone A; Fransén E; Halldin C; Farde L
    Synapse; 2010 Jun; 64(6):478-85. PubMed ID: 20175222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Normal striatal D2 receptor binding in idiopathic restless legs syndrome with periodic leg movements in sleep.
    Tribl GG; Asenbaum S; Happe S; Bonelli RM; Zeitlhofer J; Auff E
    Nucl Med Commun; 2004 Jan; 25(1):55-60. PubMed ID: 15061265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between striatal and extrastriatal dopamine D2-receptor binding and social desirability.
    Cervenka S; Gustavsson JP; Halldin C; Farde L
    Neuroimage; 2010 Mar; 50(1):323-8. PubMed ID: 20004254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride.
    Montgomery AJ; Stokes P; Kitamura Y; Grasby PM
    J Affect Disord; 2007 Aug; 101(1-3):113-22. PubMed ID: 17197036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased synaptic dopamine in the putamen in restless legs syndrome.
    Earley CJ; Kuwabara H; Wong DF; Gamaldo C; Salas RE; Brašić JR; Ravert HT; Dannals RF; Allen RP
    Sleep; 2013 Jan; 36(1):51-7. PubMed ID: 23288971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related diurnal effect on D2 receptor binding: a preliminary PET study.
    Cervenka S; Halldin C; Farde L
    Int J Neuropsychopharmacol; 2008 Aug; 11(5):671-8. PubMed ID: 18184446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET.
    Hirvonen J; Karlsson H; Kajander J; Markkula J; Rasi-Hakala H; Någren K; Salminen JK; Hietala J
    Psychopharmacology (Berl); 2008 May; 197(4):581-90. PubMed ID: 18251011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of extrastriatal dopamine D2 receptor density and affinity in the human brain using PET.
    Olsson H; Halldin C; Farde L
    Neuroimage; 2004 Jun; 22(2):794-803. PubMed ID: 15193608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D2 receptor binding in drug-naïve patients with schizophrenia examined with raclopride-C11 and positron emission tomography.
    Talvik M; Nordström AL; Okubo Y; Olsson H; Borg J; Halldin C; Farde L
    Psychiatry Res; 2006 Dec; 148(2-3):165-73. PubMed ID: 17095199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High long-term test-retest reliability for extrastriatal
    Karalija N; Jonassson L; Johansson J; Papenberg G; Salami A; Andersson M; Riklund K; Nyberg L; Boraxbekk CJ
    J Cereb Blood Flow Metab; 2020 Sep; 40(9):1859-1868. PubMed ID: 31506011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F]Fallypride PET measurement of striatal and extrastriatal dopamine D 2/3 receptor availability in recently abstinent alcoholics.
    Rominger A; Cumming P; Xiong G; Koller G; Böning G; Wulff M; Zwergal A; Förster S; Reilhac A; Munk O; Soyka M; Wängler B; Bartenstein P; la Fougère C; Pogarell O
    Addict Biol; 2012 Mar; 17(2):490-503. PubMed ID: 22023291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of endogenous dopamine on extrastriatal [¹¹C]FLB 457 binding measured by PET.
    Okauchi T; Suhara T; Maeda J; Kawabe K; Obayashi S; Suzuki K
    Synapse; 2001 Aug; 41(2):87-95. PubMed ID: 11400175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal and extrastriatal dopamine D2 receptor occupancy by a novel antipsychotic, blonanserin: a PET study with [11C]raclopride and [11C]FLB 457 in schizophrenia.
    Tateno A; Arakawa R; Okumura M; Fukuta H; Honjo K; Ishihara K; Nakamura H; Kumita S; Okubo Y
    J Clin Psychopharmacol; 2013 Apr; 33(2):162-9. PubMed ID: 23422369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striatal dopaminergic dysfunction at rest and during task performance in writer's cramp.
    Berman BD; Hallett M; Herscovitch P; Simonyan K
    Brain; 2013 Dec; 136(Pt 12):3645-58. PubMed ID: 24148273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptors as markers of brain iron deficiency: Implications for Restless Legs Syndrome.
    Quiroz C; Gulyani S; Ruiqian W; Bonaventura J; Cutler R; Pearson V; Allen RP; Earley CJ; Mattson MP; Ferré S
    Neuropharmacology; 2016 Dec; 111():160-168. PubMed ID: 27600688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.